Chapter 1. Executive Summary
Chapter 2. Scope of The Study
2.1. Market Definition
2.2. Scope of The Study
2.2.1. Objectives of Report
Chapter 3. Evolve BI Methodology
Chapter 4. Market Insights and Trends
4.1. Supply/ Value Chain Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitutes
4.2.5. Industry Rivalry
4.3. Impact of COVID-19 on Companion Diagnostics for Oncology Market
4.3.1. Impact on Market Size
4.3.2. End User Trend, Preferences and Budget Impact
4.3.3. Regulatory Framework/Government Policies
4.3.4. Key Players Strategy to Tackle Negative Impact
4.3.5. Opportunity Window
Chapter 5. Market Dynamics
5.1. Introduction
5.2. DRO Analysis
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Opportunities
Chapter 6. Global Companion Diagnostics for Oncology Market, By Technology
6.1. Introduction
6.2. Polymerase Chain Reaction (PCR)
6.3. Next-Generation Sequencing (NGS)
6.3. Immunohistochemistry (IHC)
6.4. In situ hybridization (ISH)
6.5. Fluorescence in situ hybridization (FISH)
6.6. Others
Chapter 7. Global Companion Diagnostics for Oncology Market, By Disease Type
7.1. Introduction
7.2. Breast Cancer
7.3. Non-Small Cell Lung Cancer
7.4. Colorectal Cancer
7.5. Leukemia
7.6. Melanoma
7.7. Others
Chapter 8. Global Companion Diagnostics for Oncology Market, By End-user
8.1. Introduction
8.2. Hospital
8.3. Pathology/Diagnostic Laboratory
8.4. Academic Medical Center
8.5. Others
Chapter 9. Global Companion Diagnostics for Oncology Market, By Region
9.1. Introduction
9.2. North America
9.2.1. Introduction
9.2.2. Driving Factors, Opportunity Analyzed and Key Trends
9.2.3. Market Size and Forecast, By Country, 2020 - 2028
9.2.4. Market Size and Forecast, By Technology, 2020 - 2028
9.2.5. Market Size and Forecast, By Disease Type, 2020 – 2028
9.2.6. Market Size and Forecast, By End-user, 2020 – 2028
9.2.7. US
9.2.7.1. Introduction
9.2.7.2. Driving Factors, Opportunity Analyzed and Key Trends
9.2.7.3. Market Size and Forecast, By Technology, 2020 - 2028
9.2.7.4. Market Size and Forecast, By Disease Type, 2020 – 2028
9.2.7.5. Market Size and Forecast, By End-user, 2020 - 2028
9.2.8. Canada
9.2.8.1. Introduction
9.2.8.2. Driving Factors, Opportunity Analyzed and Key Trends
9.2.8.4. Market Size and Forecast, By Technology, 2020 - 2028
9.2.8.5. Market Size and Forecast, By Disease Type, 2020 – 2028
9.2.8.6. Market Size and Forecast, By End-user, 2020 - 2028
9.3. Europe
9.3.1. Introduction
9.3.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.3. Market Size and Forecast, By Country, 2020 - 2028
9.3.4. Market Size and Forecast, By Technology, 2020 - 2028
9.3.5. Market Size and Forecast, By Disease Type, 2020 – 2028
9.3.6. Market Size and Forecast, By End-user, 2020 – 2028
9.3.7. Germany
9.3.7.1. Introduction
9.3.7.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.7.3. Market Size and Forecast, By Technology, 2020 - 2028
9.3.7.4. Market Size and Forecast, By Disease Type, 2020 – 2028
9.3.7.5. Market Size and Forecast, By End-user, 2020 - 2028
9.3.8. France
9.3.8.1. Introduction
9.3.8.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.8.3. Market Size and Forecast, By Technology, 2020 - 2028
9.3.8.4. Market Size and Forecast, By Disease Type, 2020 – 2028
9.3.8.5. Market Size and Forecast, By End-user, 2020 - 2028
9.3.9. UK
9.3.9.1. Introduction
9.3.9.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.9.3. Market Size and Forecast, By Technology, 2020 - 2028
9.3.9.4. Market Size and Forecast, By Disease Type, 2020 – 2028
9.3.9.5. Market Size and Forecast, By End-user, 2020 - 2028
9.3.10. Italy
9.3.10.1. Introduction
9.3.10.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.10.3. Market Size and Forecast, By Technology, 2020 - 2028
9.3.10.4. Market Size and Forecast, By Disease Type, 2020 – 2028
9.3.10.5. Market Size and Forecast, By End-user, 2020 - 2028
9.3.11. Rest of Europe
9.3.11.1. Introduction
9.3.11.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.11.3. Market Size and Forecast, By Technology, 2020 - 2028
9.3.11.4. Market Size and Forecast, By Disease Type, 2020 – 2028
9.3.11.5. Market Size and Forecast, By End-user, 2020 - 2028
9.4. Asia-Pacific
9.4.1. Introduction
9.4.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.3. Market Size and Forecast, By Country, 2020 - 2028
9.4.4. Market Size and Forecast, By Technology, 2020 - 2028
9.4.5. Market Size and Forecast, By Disease Type, 2020 – 2028
9.4.7. Market Size and Forecast, By End-user, 2020 - 2028
9.4.8. China
9.4.8.1. Introduction
9.4.8.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.8.3. Market Size and Forecast, By Technology, 2020 - 2028
9.4.8.4. Market Size and Forecast, By Disease Type, 2020 – 2028
9.4.8.5. Market Size and Forecast, By End-user, 2020 - 2028
9.4.9. India
9.4.9.1. Introduction
9.4.9.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.9.3. Market Size and Forecast, By Technology, 2020 - 2028
9.4.9.4. Market Size and Forecast, By Disease Type, 2020 – 2028
9.4.9.5. Market Size and Forecast, By End-user, 2020 - 2028
9.4.10. Japan
9.4.10.1. Introduction
9.4.10.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.10.3. Market Size and Forecast, By Technology, 2020 - 2028
9.4.10.4. Market Size and Forecast, By Disease Type, 2020 – 2028
9.4.10.5. Market Size and Forecast, By End-user, 2020 - 2028
9.4.11. South Korea
9.4.11.1. Introduction
9.4.11.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.11.3. Market Size and Forecast, By Technology, 2020 - 2028
9.4.11.4. Market Size and Forecast, By Disease Type, 2020 – 2028
9.4.11.5. Market Size and Forecast, By End-user, 2020 - 2028
9.4.12. Rest of Asia-Pacific
9.4.11.1. Introduction
9.4.12.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.12.3. Market Size and Forecast, By Technology, 2020 - 2028
9.4.12.4. Market Size and Forecast, By Disease Type, 2020 – 2028
9.4.12.5. Market Size and Forecast, By End-user, 2020 - 2028
9.5. Rest of The World (RoW)
9.5.1. Introduction
9.5.2. Driving Factors, Opportunity Analyzed and Key Trends
9.5.3. Market Size and Forecast, By Technology, 2020 - 2028
9.5.4. Market Size and Forecast, By Disease Type, 2020 – 2028
9.5.5. Market Size and Forecast, By End-user, 2020 - 2028
9.5.6. Market Size and Forecast, By Region, 2020 - 2028
9.5.7. South America
9.5.7.1. Introduction
9.5.7.2. Driving Factors, Opportunity Analyzed and Key Trends
9.5.7.3. Market Size and Forecast, By Technology, 2020 - 2028
9.5.7.4. Market Size and Forecast, By Disease Type, 2020 – 2028
9.5.7.5. Market Size and Forecast, By End-user, 2020 - 2028
9.5.8. Middle East & Africa
9.5.8.1. Introduction
9.5.8.2. Driving Factors, Opportunity Analyzed and Key Trends
9.5.8.3. Market Size and Forecast, By Technology, 2020 - 2028
9.5.8.4. Market Size and Forecast, By Disease Type, 2020 – 2028
9.5.8.5. Market Size and Forecast, By End-user, 2020 - 2028
Chapter 10. Competitive Landscape
10.1. Introduction
10.2. Vendor Share Analysis, 2020/Key Players Positioning 2020
Chapter 11. Company Profiles
11.1. Agilent Technologies, Inc
11.1.1. Business Overview
11.1.2. Financial Analysis
11.1.3. Product Portfolio
11.1.4. Recent Development and Strategies Adopted
11.1.5. SWOT Analysis
11.2. QIAGEN N.V.
11.2.1. Business Overview
11.2.2. Financial Analysis
11.2.3. Product Portfolio
11.2.4. Recent Development and Strategies Adopted
11.2.5. SWOT Analysis
11.3. Thermo Fisher Scientific, Inc.
11.3.1. Business Overview
11.3.2. Financial Analysis
11.3.3. Product Portfolio
11.3.4. Recent Development and Strategies Adopted
11.3.5. SWOT Analysis
11.4. F. Hoffmann-La Roche Ltd.
11.4.1. Business Overview
11.4.2. Financial Analysis
11.4.3. Product Portfolio
11.4.4. Recent Development and Strategies Adopted
11.4.5. SWOT Analysis
11.5. ARUP Laboratories
11.5.1. Business Overview
11.5.2. Financial Analysis
11.5.3. Product Portfolio
11.5.4. Recent Development and Strategies Adopted
11.5.5. SWOT Analysis
11.6. Abbott
11.6.1. Business Overview
11.6.2. Financial Analysis
11.6.3. Product Portfolio
11.6.4. Recent Development and Strategies Adopted
11.6.5. SWOT Analysis
11.7. Myriad Genetics, Inc.
11.7.1. Business Overview
11.7.2. Financial Analysis
11.7.3. Product Portfolio
11.7.4. Recent Development and Strategies Adopted
11.7.5. SWOT Analysis
11.8. bioMérieux SA
11.8.1. Business Overview
11.8.2. Financial Analysis
11.8.3. Product Portfolio
11.8.4. Recent Development and Strategies Adopted
11.8.5. SWOT Analysis
11.9. Illumina, Inc.
11.9.1. Business Overview
11.9.2. Financial Analysis
11.9.3. Product Portfolio
11.9.4. Recent Development and Strategies Adopted
11.9.5. SWOT Analysis
11.10. Invivoscribe, Inc.
11.10.1. Business Overview
11.10.2. Financial Analysis
11.10.3. Product Portfolio
11.9.4. Recent Development and Strategies Adopted
11.9.5. SWOT Analysis
Chapter 12. Key Takeaways